Sciot R, Paterson A C, Van den Oord J J, Desmet V J
Departement Medische Navorsing, Universitair Ziekenhuis St. Rafaël, Leuven, Belgium.
Hepatology. 1987 Sep-Oct;7(5):831-7. doi: 10.1002/hep.1840070507.
The major part of hepatocellular iron is derived from uptake of transferrin-bound iron by means of nonspecific fluid-phase endocytosis and specific, saturable binding on high-affinity transferrin receptors. We investigated the expression of transferrin receptors on hepatocytes in liver biopsies of 22 cases of hemochromatosis (21 primary hemochromatosis and 1 secondary hemochromatosis), using immunohistochemical demonstration of the human transferrin receptor with the specific monoclonal antibody OKT9. Fifty liver biopsies (normal and pathological) without demonstrable iron storage (Perls' stain negative) served as controls. In the controls, membranous and/or cytoplasmic transferrin receptor expression was always present on hepatocytes, albeit in variable numbers and patterns without obvious relation to the underlying liver disease. In 19 of 22 hemochromatosis cases with severe iron overload, OKT9 immunoreactivity on hepatocytes was completely absent. Three hemochromatosis cases showed few hepatocytes positive for OKT9. One showed mild iron overload, while the second, a successfully treated case, was free of iron. The remaining hemochromatosis case was a known alcoholic with severe iron overload. Since OKT9 binding to the transferrin receptor is not blocked by previous binding of transferrin, the findings show that in advanced hemochromatosis hepatocytes do not express transferrin receptors. This finding is in keeping with the inverse relation between transferrin receptor expression and exogenous iron supply in various cell cultures. These results indicate that in hemochromatosis,apparently as a result of progressive iron overload,transferrin receptor expression on hepatocytes disappears.(ABSTRACT TRUNCATED AT 250 WORDS)
肝细胞内的铁主要来源于通过非特异性液相内吞作用摄取转铁蛋白结合的铁,以及通过高亲和力转铁蛋白受体进行特异性、可饱和的结合。我们使用特异性单克隆抗体OKT9对转铁蛋白受体进行免疫组织化学检测,以研究22例血色素沉着症(21例原发性血色素沉着症和1例继发性血色素沉着症)肝活检中肝细胞上转铁蛋白受体的表达情况。50例无明显铁储存(Perls染色阴性)的肝活检标本(正常和病理标本)作为对照。在对照组中,肝细胞上始终存在膜性和/或细胞质转铁蛋白受体表达,尽管数量和模式各不相同,且与潜在的肝脏疾病无明显关联。在22例铁过载严重的血色素沉着症病例中,有19例肝细胞上完全没有OKT9免疫反应性。3例血色素沉着症病例显示少数肝细胞OKT9呈阳性。1例显示轻度铁过载,另1例是成功治疗的病例,体内无铁。其余的血色素沉着症病例是一名已知的酗酒者,铁过载严重。由于OKT9与转铁蛋白受体的结合不会被转铁蛋白先前的结合所阻断,这些发现表明,在晚期血色素沉着症中,肝细胞不表达转铁蛋白受体。这一发现与各种细胞培养中转铁蛋白受体表达与外源性铁供应之间的负相关关系一致。这些结果表明,在血色素沉着症中,肝细胞上转铁蛋白受体的表达消失显然是渐进性铁过载的结果。(摘要截短于250词)